Drugs / R-343
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01591044 Comparator | Jul 2012 → Jul 2013 | asthma | Rigel Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | R-343 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2170582 ↗ |
| Known as | R940343 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01591044 ↗ |
| Action | Inhibit | “Tyrosine-protein kinase SYK inhibitor” CHEMBL2170582 ↗ |
| Modality | Small molecule | — CHEMBL2170582 ↗ |
| Target | SYK | “Tyrosine-protein kinase SYK inhibitor” CHEMBL2170582 ↗ |